Nature Outlook |

Inflammatory bowel disease

Nature is pleased to acknowledge financial support from Salix Pharmaceuticals in producing this Outlook. The sponsor retains sole responsibility for the following messages.

Salix Pharmaceuticals is headquartered in Bridgewater, New Jersey and is a specialty pharmaceutical company committed to advancing the treatment of many chronic gastrointestinal disorders. For more than 20 years, Salix has licensed, developed, and marketed innovative products to provide healthcare professionals and patients solutions for the management of chronic and debilitating conditions. Salix currently markets its product line through dedicated, specialty sales groups to U.S. healthcare providers in the areas of gastroenterology, hepatology, internal medicine, primary care, and infectious disease.

Read the sponsor’s message.

For more information, please visit www.salix.com.